Delivery Order SPE2DX22D0049-SPE2D826FA4EU

Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,441.14 by the Department of Defense Medical Supply Chain on February 2, 2026, with an ultimate completion date of February 3, 2026. This firm fixed-price contract represents a child delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The award was not set aside and was competitively awarded, consistent with Amerisourcebergen's standard federal procurement approach. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc., which holds the overarching $999.99 million IDC serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.

This delivery order exemplifies the routine pharmaceutical supply fulfillment that occurs under the Defense Logistics Agency's prime vendor program, which enables rapid delivery of critical medical commodities including specialty medications, generic and brand-name drugs, vaccines, and specialized medical supplies to military treatment facilities and veteran healthcare systems worldwide. Amerisourcebergen's extensive contract portfolio with the Defense Health Agency and other federal healthcare systems demonstrates its capability to meet varied pharmaceutical procurement requirements ranging from small-value transactions to substantial orders, supporting the operational readiness of the Department of Defense medical infrastructure.